Mental health care is often built around patience.
Patients are encouraged to give treatments time to work. Providers say that improvement can be gradual. People assume symptoms will eventually ease if everyone stays the course.
This approach works for some patients. But for many, waiting becomes an obstacle in care.
In outpatient behavioral health settings, the pace of symptom improvement can affect patient outcomes, appointment adherence, staffing, and more.
Timeline Shapes Patient Engagement
Delayed improvement is a sign to reassess in most areas of medicine. In mental health care, it is often an expectation.
For example, traditional medications can take several weeks to show measurable improvement. During that time, patients may continue experiencing symptoms that interfere with their work, family life, and basic functioning. Some can tolerate the wait. Others give up before a provider has the chance to adjust the treatment plan.
According to the National Institute of Mental Health, a significant portion of patients with major depressive disorder do not experience adequate relief after initial treatment attempts. Each additional trial extends the timeline further, increasing the risk of dropout.
Delayed symptom improvement can cause an increase in missed appointments and crisis visits, and providers spend more time managing frustration and uncertainty rather than progress. Timelines can influence patient outcomes.
Faster-acting Interventions
Faster-acting mental health treatments have received increased attention in recent years, particularly for patients who have not responded to traditional approaches.
Ketamine therapy, for example, administered in controlled medical settings, works on the brain’s glutamate system rather than the serotonin pathways targeted by most antidepressants. Some patients report symptom changes within hours or days.
The Cleveland Clinic notes that ketamine infusion therapy, when delivered under appropriate supervision, has been associated with rapid reductions in depressive symptoms and suicidal ideation.
It is not a first-line treatment, nor is it appropriate for every patient. But its emergence has widened the conversation around how quickly relief can occur under certain circumstances.
Using faster-acting therapies doesn’t mean comprehensive care is ineffective. It’s an approach available because some patients may need early stabilization before longer-term strategies can work.
Patients who see results more quickly are more likely to remain engaged in their care and participate in follow-up. Seeing improvement can make it easier for patients to stay connected to their treatment. This reduces the likelihood of early disengagement.
Outpatient Interventions
Ketamine infusions are administered under medical supervision, with patients observed throughout and after each session. Transcranial magnetic stimulation (TMS), another non-invasive method, targets specific brain regions involved in mood regulation.
Most patients complete 6-8 weeks of TMS sessions. While it doesn’t produce immediate results for every patient, it offers a structured, non-medicated option that fits well in patients’ daily routines and lifestyles.
Research published in Frontiers in Psychiatry shows that combination approaches may improve outcomes for individuals with treatment-resistant depression. These layered strategies are increasingly common in outpatient behavioral health settings, where flexibility is essential.
For example, a case study from 2025 examines combined ketamine therapy and TMS. Results showed a patient reported resolution of suicidal ideation and a return to baseline functioning after only three weeks of combined treatment.
Supporting Long-term Care
Our providers emphasize that faster symptom relief is a starting point, not the end goal.
When patients experience early improvement, they better engage in ongoing care, and other therapies become more effective. Life feels possible rather than overwhelming.
The conversation around treatment timelines is about recognizing that time itself is a clinical variable that affects patient trust, outcomes, engagement, and more.
Early symptom improvement helps the clinical and patient side. For providers, it can ease burnout and increase retention. For patients, it can mean the difference between trying and giving up.
As outpatient mental health care continues to evolve, the focus is shifting from asking patients “stick it out” to asking how the process can better support them.
Progress is a Process
Mental health recovery is rarely linear, and no single treatment works for everyone.
Faster-acting interventions are not a shortcut or a cure. They are tools that are useful in specific contexts, for specific patients, under provider oversight.
They challenge the idea that suffering must always be prolonged before improvement begins. They invite healthcare systems to consider how timing influences care delivery just as much as treatment choice.
In a field where patience has long been necessary, clarity around timelines may be just as important.

Dr. TeeJay Tripp
Dr. TeeJay Tripp, DO, is a board-certified psychiatrist and the visionary behind Serenity Mental Health Centers. Widely recognized as one of the leading psychiatrists in the Phoenix area, Dr. Tripp is dedicated to helping patients find lasting relief through personalized, evidence-based care. His philosophy centers on hope, empowerment, and restoring choice in each patient’s recovery journey.
Dr. Tripp began his career in Gilbert, Arizona, where he witnessed the transformative power of Transcranial Magnetic Stimulation (TMS) for individuals with treatment-resistant depression and other mental health conditions. Inspired by these outcomes, he set out to make advanced, compassionate mental health care more accessible nationwide.
Under his leadership as Chief Medical Officer, Serenity has grown into a comprehensive network of mental health clinics offering TMS therapy, ketamine treatment, and medication management. Dr. Tripp holds dual board certifications in General Psychiatry and Child and Adolescent Psychiatry and earned his medical degree from Midwestern University’s Arizona College of Osteopathic Medicine.
Through his continued innovation and patient-centered vision, Dr. Tripp remains committed to advancing modern psychiatric care and helping individuals take back their lives from mental illness.






